IDEXX Laboratories, Inc.
$572.11
+9.20 · +1.63% today
Market open · updated 12:45:29 PM ET
- High
- $576.84 4:05 AM
- Low
- $510.99 5:50 AM
Against the S&P 500 Price change through Oct 28, 2026
IDXX−16.79%
S&P 500+13.26%
IDXX−11.26%
S&P 500+12.41%
IDXX+43.83%
S&P 500+88.06%
IDXX−13.80%
S&P 500+68.51%
Key numbers
- Previous close
- $562.91
- Open
- $570.17
- Day's range
- $568.01 – $573.61
- 52-week range
- $500.61 – $769.98
- Volume
- 91,172
- Average volume
- 576,783
- Market value
- $45.1 billion
- Price to earnings
- 39.5last 12 months
- Earnings per share
- $14.23last 12 months
- Beta
- 1.55moves about 1.5× as much as the market
- Dividend
- None
- 50-day average
- $533.89
- 200-day average
- $574.11
Monday, Nov 2, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who IDEXX Laboratories buys from and competes with From our value chain
IDEXX Laboratories in the news
- HeadlineGear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research · October 28, 2026 at 10:16 AM ET
- HeadlineIdexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · October 26, 2026 at 11:01 AM ET
- Company earningsThermo Fisher Scientific tops Q3 estimates, but shares slide premarketWiseView Research desk · October 21, 2026
- HeadlineWill Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · October 20, 2026 at 1:11 PM ET
- HeadlineThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarZacks Investment Research · October 20, 2026 at 9:56 AM ET
- HeadlineIdexx (IDXX) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research · October 19, 2026 at 1:01 PM ET
- CongressRo Khanna bought $1,001 - $15,000 of IDXXHouse filing · disclosed Oct 9, 2026
- CongressRo Khanna sold $15,001 - $50,000 of IDXXHouse filing · disclosed Oct 9, 2026
Earnings
Next report: Monday, Nov 2, 2026, before the open.
Congress trades in IDXX
2 purchases and 6 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 25, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $15,001 - $50,000 | Sep 11, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Apr 13, 2026 | May 13, 2026 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Jan 13, 2026 | Feb 3, 2026 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Dec 2, 2025 | Jan 6, 2026 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Oct 29, 2025 | Nov 5, 2025 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Oct 16, 2025 | Nov 5, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 11,000
- Headquarters
- Westbrook, Maine
- Website
- idexx.com
- Listed
- Jun 21, 1991
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.